Report Detail

Pharma & Healthcare Global Orthopedic Hyaluronic Acid Viscosupplementation Market Insights, Forecast to 2025

  • RnM2704028
  • |
  • 22 May, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Viscosupplementation is a medical treatment for knee osteoarthritis during which lubricating fluid is injected into the knee joint to reduce pain symptoms.
The global Orthopedic Hyaluronic Acid Viscosupplementation market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orthopedic Hyaluronic Acid Viscosupplementation market based on company, product type, end user and key regions.

This report studies the global market size of Orthopedic Hyaluronic Acid Viscosupplementation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Orthopedic Hyaluronic Acid Viscosupplementation in these regions.
This research report categorizes the global Orthopedic Hyaluronic Acid Viscosupplementation market by top players/brands, region, type and end user. This report also studies the global Orthopedic Hyaluronic Acid Viscosupplementation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Anika Therapeutics
Sanofi 
Zimmer Biomet
Meda
Ferring
Fidia Pharmaceutici
Bioventus

Market size by Product
Single Injection
Three Injection
Five Injection
Market size by End User
Hospitals
Ambulatory Surgical Centres
Orthopaedic Clinics

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Orthopedic Hyaluronic Acid Viscosupplementation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Orthopedic Hyaluronic Acid Viscosupplementation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Orthopedic Hyaluronic Acid Viscosupplementation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Orthopedic Hyaluronic Acid Viscosupplementation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Orthopedic Hyaluronic Acid Viscosupplementation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orthopedic Hyaluronic Acid Viscosupplementation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Orthopedic Hyaluronic Acid Viscosupplementation Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size Growth Rate by Product
      • 1.4.2 Single Injection
      • 1.4.3 Three Injection
      • 1.4.4 Five Injection
    • 1.5 Market by End User
      • 1.5.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centres
      • 1.5.4 Orthopaedic Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Size
      • 2.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue 2014-2025
      • 2.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales 2014-2025
    • 2.2 Orthopedic Hyaluronic Acid Viscosupplementation Growth Rate by Regions
      • 2.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Regions
      • 2.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Orthopedic Hyaluronic Acid Viscosupplementation Sales by Manufacturers
      • 3.1.1 Orthopedic Hyaluronic Acid Viscosupplementation Sales by Manufacturers
      • 3.1.2 Orthopedic Hyaluronic Acid Viscosupplementation Sales Market Share by Manufacturers
      • 3.1.3 Global Orthopedic Hyaluronic Acid Viscosupplementation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Manufacturers
      • 3.2.1 Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Manufacturers (2014-2019)
      • 3.2.2 Orthopedic Hyaluronic Acid Viscosupplementation Revenue Share by Manufacturers (2014-2019)
    • 3.3 Orthopedic Hyaluronic Acid Viscosupplementation Price by Manufacturers
    • 3.4 Orthopedic Hyaluronic Acid Viscosupplementation Manufacturing Base Distribution, Product Types
      • 3.4.1 Orthopedic Hyaluronic Acid Viscosupplementation Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Orthopedic Hyaluronic Acid Viscosupplementation Product Type
      • 3.4.3 Date of International Manufacturers Enter into Orthopedic Hyaluronic Acid Viscosupplementation Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales by Product
    • 4.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Product
    • 4.3 Orthopedic Hyaluronic Acid Viscosupplementation Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Breakdown Data by End User

    6 North America

    • 6.1 North America Orthopedic Hyaluronic Acid Viscosupplementation by Countries
      • 6.1.1 North America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Countries
      • 6.1.2 North America Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Orthopedic Hyaluronic Acid Viscosupplementation by Product
    • 6.3 North America Orthopedic Hyaluronic Acid Viscosupplementation by End User

    7 Europe

    • 7.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation by Countries
      • 7.1.1 Europe Orthopedic Hyaluronic Acid Viscosupplementation Sales by Countries
      • 7.1.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Orthopedic Hyaluronic Acid Viscosupplementation by Product
    • 7.3 Europe Orthopedic Hyaluronic Acid Viscosupplementation by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation by Countries
      • 8.1.1 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Sales by Countries
      • 8.1.2 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation by Product
    • 8.3 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation by End User

    9 Central & South America

    • 9.1 Central & South America Orthopedic Hyaluronic Acid Viscosupplementation by Countries
      • 9.1.1 Central & South America Orthopedic Hyaluronic Acid Viscosupplementation Sales by Countries
      • 9.1.2 Central & South America Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Orthopedic Hyaluronic Acid Viscosupplementation by Product
    • 9.3 Central & South America Orthopedic Hyaluronic Acid Viscosupplementation by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation by Countries
      • 10.1.1 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Sales by Countries
      • 10.1.2 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation by Product
    • 10.3 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation by End User

    11 Company Profiles

    • 11.1 Anika Therapeutics
      • 11.1.1 Anika Therapeutics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Anika Therapeutics Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.1.5 Anika Therapeutics Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 Zimmer Biomet
      • 11.3.1 Zimmer Biomet Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Zimmer Biomet Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.3.5 Zimmer Biomet Recent Development
    • 11.4 Meda
      • 11.4.1 Meda Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Meda Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Meda Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.4.5 Meda Recent Development
    • 11.5 Ferring
      • 11.5.1 Ferring Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Ferring Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.5.5 Ferring Recent Development
    • 11.6 Fidia Pharmaceutici
      • 11.6.1 Fidia Pharmaceutici Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Fidia Pharmaceutici Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Fidia Pharmaceutici Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.6.5 Fidia Pharmaceutici Recent Development
    • 11.7 Bioventus
      • 11.7.1 Bioventus Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bioventus Orthopedic Hyaluronic Acid Viscosupplementation Products Offered
      • 11.7.5 Bioventus Recent Development

    12 Future Forecast

    • 12.1 Orthopedic Hyaluronic Acid Viscosupplementation Market Forecast by Regions
      • 12.1.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Forecast by Regions 2019-2025
    • 12.2 Orthopedic Hyaluronic Acid Viscosupplementation Market Forecast by Product
      • 12.2.1 Global Orthopedic Hyaluronic Acid Viscosupplementation Sales Forecast by Product 2019-2025
      • 12.2.2 Global Orthopedic Hyaluronic Acid Viscosupplementation Revenue Forecast by Product 2019-2025
    • 12.3 Orthopedic Hyaluronic Acid Viscosupplementation Market Forecast by End User
    • 12.4 North America Orthopedic Hyaluronic Acid Viscosupplementation Forecast
    • 12.5 Europe Orthopedic Hyaluronic Acid Viscosupplementation Forecast
    • 12.6 Asia Pacific Orthopedic Hyaluronic Acid Viscosupplementation Forecast
    • 12.7 Central & South America Orthopedic Hyaluronic Acid Viscosupplementation Forecast
    • 12.8 Middle East and Africa Orthopedic Hyaluronic Acid Viscosupplementation Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Orthopedic Hyaluronic Acid Viscosupplementation Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Orthopedic Hyaluronic Acid Viscosupplementation . Industry analysis & Market Report on Orthopedic Hyaluronic Acid Viscosupplementation is a syndicated market report, published as Global Orthopedic Hyaluronic Acid Viscosupplementation Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Orthopedic Hyaluronic Acid Viscosupplementation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,159.00
      4,738.50
      6,318.00
      3,662.10
      5,493.15
      7,324.20
      603,564.00
      905,346.00
      1,207,128.00
      325,260.00
      487,890.00
      650,520.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report